Cargando…
Weight-centric treatment of type 2 diabetes mellitus
BACKGROUND: Chronic non-communicable diseases (CNCD) represent a major cause of morbidity and mortality. Type 2 diabetes mellitus (T2DM) is one of the most prevalent CNCD that is associated with a significant medical and economic burden. One of the main modifiable risk factors of T2DM is obesity. Ma...
Autores principales: | Ghusn, Wissam, Hurtado, Maria Daniela, Acosta, Andres |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662009/ https://www.ncbi.nlm.nih.gov/pubmed/37990663 http://dx.doi.org/10.1016/j.obpill.2022.100045 |
Ejemplares similares
-
Weight-centric treatment of depression and chronic pain
por: Ghusn, Wissam, et al.
Publicado: (2022) -
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
por: Ghusn, Wissam, et al.
Publicado: (2022) -
FRI078 Real-World Weight Loss Outcomes And Safety Of Tirzepatide, A Novel Dual GIP And GLP-1 Receptor Agonist
por: Fansa, Sima, et al.
Publicado: (2023) -
A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
por: De la Rosa, Alan, et al.
Publicado: (2022) -
1156: A COMPARISON BETWEEN REAL WORLD WEIGHT LOSS OUTCOMES WITH ANTI-OBESITY MEDICATIONS BEFORE AND DURING COVID-19 PANDEMIC
por: Rosa, Alan De la, et al.
Publicado: (2022)